You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

84 Results
Guidelines and Advice
Status: Archived
ID: 11-10
Oct 2015
Guidelines and Advice
Status: Current
ID: ES 11-13
Feb 2021
Regimen
Cancer Type:
Sarcoma, 
Giant Cell Tumour
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Drugs Used:
denosumab (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2024
Regimen
Cancer Type:
Gynecologic, 
Endometrial, 
Ovary, 
Uterine Sarcoma, 
Vulva, 
Sarcoma, 
Uterine
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
CARBOplatin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2019
Guidelines and Advice
Status: Current
ID: 11-6
Version: 2
Feb 2022
Regimen
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
iMAtinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Oct 2024
Regimen
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    SUNItinib - Unresectable or metastatic/recurrent Gastrointestinal Stromal Tumour, with specific criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
SUNItinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Oct 2020
Guidelines and Advice
Status: Current
Version: 1.0
Mar 2023
Guidelines and Advice
Status: In-Review
ID: 19-6
Apr 2016
Guidelines and Advice
Status: Archived
ID: GL 11-11
Jul 2012
Guidelines and Advice
Status: Archived
ID: 11-7
Version: 3
May 2015
Guidelines and Advice
Status: Archived
ID: 21-3-6
Oct 2010

Pages